UMDF Bench-to-Bedside Clinical Trials Update – Part 2
January 13 @ 12:00 pm - 1:00 pm
UMDF Bench-to-Bedside – Clinical Trials Update – Part 2
Moderator: Philip Yeske, PhD and Zuela Zolkipli Cunningham, MD
The Effects of L-arginine on Cerebrovascular Reactivity, Perfusion and Neurovascular Coupling in MELAS Syndrome
Speaker: Ingrid Tein, BSc, MD, FRCP(C) – Hospital for Sick Children (SickKids), Toronto, CA
Clinical Trial Updates – Part 2 – Presenters:
-
- Fernando Scaglia, MD – Baylor College of Medicine, Houston, TX
- Jan Smeitink, MD, PhD – Khondrion
- Chad Glasser, PharmD, MPH – Tisento Therapeutics
- Magnus Hansson, MD, PhD – Abliva
Time: 12:00pm ET/11:00am CT/9:00a PT
